Non-O1/non-O139 Vibrio cholerae bacteremia and hepatitis in diabetic patient, France, winter 2019

Diagn Microbiol Infect Dis. 2024 Sep;110(1):116371. doi: 10.1016/j.diagmicrobio.2024.116371. Epub 2024 Jun 2.

Abstract

Objectives: Vibrio cholerae non-O1/non-O139 (NOVC) bacteremia is infrequently reported in Western countries and is associated with unfavorable outcome.

Patient/method: We describe here the case of a diabetic patient with hepatic cytolysis and NOVC bacteremia following an episode of diarrhea.

Result: The patient was paucisymptomatic and had a favorable resolution with oral ciprofloxacin.

Conclusion: NOVC should be systematically sought in stool samples, particularly in immunocompromised patients, due to an increased risk of infection occurrence.

Keywords: Bacteremia; Detection; Global warming; Non Vibrio cholerae.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents* / therapeutic use
  • Bacteremia* / drug therapy
  • Bacteremia* / microbiology
  • Cholera / complications
  • Cholera / microbiology
  • Ciprofloxacin / therapeutic use
  • Diarrhea / microbiology
  • Feces / microbiology
  • Female
  • France / epidemiology
  • Hepatitis / complications
  • Hepatitis / microbiology
  • Humans
  • Male
  • Middle Aged
  • Vibrio Infections / diagnosis
  • Vibrio Infections / drug therapy
  • Vibrio Infections / microbiology
  • Vibrio cholerae non-O1* / classification
  • Vibrio cholerae non-O1* / genetics
  • Vibrio cholerae non-O1* / isolation & purification

Substances

  • Anti-Bacterial Agents
  • Ciprofloxacin